# Achieving Value in Cancer Diagnostics: Blood Versus Tissue Molecular Profiling - a Prospective Canadian Study

> **NCT03576937** · — · COMPLETED · sponsor: **University Health Network, Toronto** · enrollment: 207 (actual)

## Conditions studied

- Non-small Cell Lung Cancer

## Interventions

- **DIAGNOSTIC_TEST:** GUARDANT360

## Key facts

- **NCT ID:** NCT03576937
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-02-12
- **Primary completion:** 2020-10-30
- **Final completion:** 2023-04-30
- **Target enrollment:** 207 (ACTUAL)
- **Last updated:** 2023-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03576937

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03576937, "Achieving Value in Cancer Diagnostics: Blood Versus Tissue Molecular Profiling - a Prospective Canadian Study". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03576937. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*